Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms
    4.
    发明授权
    Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms 失效
    用含3至5个碳原子的酮糖交联蛋白质的方法

    公开(公告)号:US08034582B2

    公开(公告)日:2011-10-11

    申请号:US11012485

    申请日:2004-12-16

    摘要: The present invention relates to a process for crosslinking proteins, according to which the crosslinking agent is a ketose containing 3 to 5 carbon atoms and said proteins are chosen from the group comprising proteins from animal tissues, from milk or from blood, such as in particular casein, gelatin or collagen; proteins from cereals, such as in particular maize, wheat or rice proteins; protein from high-protein plants, such as in particular pea, alfalfa, lupin, barley, millet or sorghum proteins; proteins from oleaginous plants, such as in particular soybean proteins, for instance soybean cakes, rapeseed or flax proteins, for instance rapeseed cakes, sunflower, groundnut or cotton proteins; and proteins from tubers, such as in particular from potato or manioc.

    摘要翻译: 本发明涉及交联蛋白质的方法,根据该方法,交联剂是含有3-5个碳原子的酮糖酮,所述蛋白质选自包含来自动物组织,牛奶或血液的蛋白质的组 酪蛋白,明胶或胶原蛋白; 来自谷物的蛋白质,特别是玉米,小麦或水稻蛋白质; 蛋白质,例如特别是豌豆,苜蓿,羽扇豆,大麦,小米或高粱蛋白质的蛋白质; 来自油质植物的蛋白质,例如特别是大豆蛋白质,例如大豆蛋糕,油菜籽或亚麻蛋白质,例如油菜籽蛋糕,向日葵,花生或棉花蛋白质; 和来自块茎的蛋白质,特别是来自马铃薯或manioc的蛋白质。

    Antipyretic preparation containing xylitol
    8.
    发明申请

    公开(公告)号:US20060142254A1

    公开(公告)日:2006-06-29

    申请号:US11360594

    申请日:2006-02-24

    IPC分类号: A61K31/60 A61K31/045

    摘要: The invention relates to an antipyretic preparation intended to be administered by any means other than orally, characterized in that it comprises xylitol, and more particularly to an antipyretic preparation characterized in that it consists of an antipyretic and a synergistic amount of xylitol. The invention also relates to the use of this antipyretic preparation in pharmaceutical applications, in which the xylitol can then be used as a medicinal product with an antipyretic effect, for example in combination with another medicinal product of the family of antipyretic analgesics which may or may not have anti-inflammatory action. It also relates to its use in the treatment of infections chosen from the group of parasitic, viral and bacterial infections, but also in the treatment of heatstroke, burns, poisoning with a chemical product or any disturbance of the function of body temperature regulation.

    Use of polysaccharides for treating stress and anxiety
    9.
    发明授权
    Use of polysaccharides for treating stress and anxiety 有权
    使用多糖治疗压力和焦虑

    公开(公告)号:US08871740B2

    公开(公告)日:2014-10-28

    申请号:US13519006

    申请日:2010-12-23

    摘要: The present invention relates to a composition including a mix of a polysaccharides having: 15% to 50% of glucoside linkages 1-6; a reducing sugar content of less than 20%; a polymolecularity index of less than 5; an average molecular weight with number Mn of less than 4500 g/mole and at least one active agent for treating stress, anxiety and depressive behavior, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals. The present invention also relates to the use of the polysaccharide for treating stress, anxiety or depressive behavior, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals.

    摘要翻译: 本发明涉及包含多糖的混合物的组合物,所述多糖具有:15%至50%的葡萄糖苷键1-6; 还原糖含量小于20%; 多分子指数小于5; 数量Mn小于4500g / mol的平均分子量和用于治疗人或动物中的压力,焦虑和抑郁行为,睡眠障碍,强迫症,贪食症和癫痫的至少一种活性剂。 本发明还涉及多糖用于治疗人或动物中的压力,焦虑或抑郁行为,睡眠障碍,强迫症,贪食症和癫痫的用途。

    USE OF POLYSACCHARIDES FOR TREATING STRESS AND ANXIETY
    10.
    发明申请
    USE OF POLYSACCHARIDES FOR TREATING STRESS AND ANXIETY 有权
    多糖用于治疗压力和抗氧化剂的应用

    公开(公告)号:US20120283212A1

    公开(公告)日:2012-11-08

    申请号:US13519006

    申请日:2010-12-23

    摘要: The present invention relates to a composition including a mix of a polysaccharides having: 15% to 50% of glucoside linkages 1-6; a reducing sugar content of less than 20%; a polymolecularity index of less than 5; an average molecular weight with number Mn of less than 4500 g/mole and at least one active agent for treating stress, anxiety and depressive behaviour, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals. The present invention also relates to the use of the polysaccharide for treating stress, anxiety or depressive behaviour, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals.

    摘要翻译: 本发明涉及包含多糖的混合物的组合物,所述多糖具有:15%至50%的葡萄糖苷键1-6; 还原糖含量小于20%; 多分子指数小于5; 数量Mn小于4500g / mol的平均分子量和用于治疗人或动物中的压力,焦虑和抑郁行为,睡眠障碍,强迫症,贪食症和癫痫的至少一种活性剂。 本发明还涉及多糖用于治疗人或动物中的压力,焦虑或抑郁行为,睡眠障碍,强迫症,贪食症和癫痫的用途。